Gas foaming to fabricate polymer scaffolds in tissue engineering

Scaffolding in Tissue Engineering

Volumn , Issue , 2005, Pages 155-168

  Huang, Yen Chen ^a   Mooney, David J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36949011681     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (62)

1. Wong, W. H., and Mooney, D., Synthesis and properties of biodegradable polymers used as synthetic matrices for tissue engineering, In Synthetic Biodegradable Polymer Scaffolds, Atala, A., and Mooney, D., eds., Birkhauser, Boston, pp. 51-82, 1997.
2. Kim, B. S., and Mooney, D. J., Development of biocompatible synthetic extracellular matrices for tissue engineering, Trends Biotechnol., 16(5), 224-230, 1998.
3. Burg, K. J., Porter, S., and Kellam, J. F., Biomaterial developments for bone tissue engineering, Biomaterials, 21(23), 2347-2359, 2000.
4. Huang, S. J., Biodegradable polymers, In Polymers-Biomaterials and Medical Application, Kroshwitz, I. J., ed., Wiley, New York, 1989.
5. Lo, H., Ponticiello, M. S., and Leong, K. W., Fabrication of controlled release biodegradable foams by phase seperation, Tissue Eng., 1, 15-28, 1995.
6. Mikos, A. G., Thorsen, A. J., Czerwonka, L. A., Bao, Y., and Langer, R., Preparation and characterization of poly(L-lactic acid) foams, Polymer, 35, 1068-1077, 1994.
7. Hile, D. D., Amirpour, M. L., Akgerman, A., and Pishko, M. V., Active growth factor delivery from poly(D.L-lactide-co-glycolide) foams prepared in supercritical CO(2), J Controlled Release, 66(2-3), 177-185, 2000.
8. Howdle, S. M., Michael, S. W., Whitaker, M. J., Popov, V. K., Davies, M. C., Mandel, F. S., Wang, J. D., and Shakesheff, K. M., Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials, Chem. Commun., 109-110, 2001.
9. Freed, L. E., Vunjak-Novakovic, G., Biron, R. J., Eagles, D. B., Lesnoy, D. C., Barlow, S. K., and Langer, R., Biodegradable polymer scaffolds for tissue engineering, Biotechnology (NY), 12(7), 689-693, 1994.
10. Harris, L. D., Kim, B. S., and Mooney, D. J., Open pore biodegradable matrices formed with gas foaming, J. Biomed. Mater. Res., 42(3), 396-402, 1998.
11. Kim, B. S., and Mooney, D. J., Development of biocompatible synthetic extracellular matrices for tissue engineering, Trends Biotechnol., 16(5), 224-230, 1998.
12. Thomson, R. C., Yaszemski, M. J., Powers, J. M., and Mikos, A. G., Fabrication of biodegradable polymer scaffolds to engineer trabecular bone, J. Biomater. Sci. Polym. Ed., 7(1), 23-38, 1995.
13. Thomson, R. C., Mikos, A. G., Beahm, E., Lemon, J. C., Satterfield, W. C., Aufdemorte, T. B., and Miller, M. J., Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds, Biomaterials, 20(21), 2007-2018, 1999.
14. Gilding, D. K., Biodegradable polymers, In Biocompatibility of Clinical Implant Materials, Williams, D. F., ed., CRC Press, Boca Raton, FL, 1981.
15. Shea, L. D., Smiley, E., Bonadio, J., and Mooney, D. J., DNA delivery from polymer matrices for tissue engineering, Nat. Biotechnol., 17(6), 551-554, 1999.
16. Mooney, D. J., Baldwin, D. F., Suh, N. P., Vacanti, J. P., and Langer, R., Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents, Biomaterials, 17, 1417-1422, 1996.
17. Kazarian, S. G., Vincent, M. F., Bright, F. V., Liotta, C. L., and Eckert, C. A., Specific intermolecular interaction of carbon dioxide with polymers, J. Am. Chem. Soc., 118, 1729-1736, 1996.
18. Sheridan, M. H., Shea, L. D., Peters, M. C., and Mooney, D. J., Bioadsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery, J. Controlled Release, 64(1-3), 91-102, 2000.
19. Richardson, T. P., Peters, M. C., and Mooney, D. J., Processing of polymer scaffolds: gas foaming process, In Methods of Tissue Engineering, Atala, A., and Lanza, R., eds., Academic Press, New York, pp. 733-740, 2002.
20. Murphy, W. L., Dennis, R. G., Kileny, J. L., and Mooney, D. J., Salt fusion: an approach to improve pore interconnectivity within tissue engineering scaffolds, Tissue Eng., 8(1), 43-52, 2002.
21. Khan, T. A., Sellke, F. W., and Laham, R. J., Ther. Angiogenesis Coron. Artery Dis., 4(1), 65-74, 2002.
22. Laham, R., Angiogenesis (clinical trials), Can J Cardiol, 17(Suppl A), 29A-32A, 2001.
23. Post, M. J., Laham, R., Selke, F. W., and Simons, M., Therapeutic angiogenesis in cardiology using protein formulations, Cardiovasc. Res., 49(3), 522-531, 2001.
24. Freedman, S. B., and Isner, J. M., Therapeutic angiogenesis for coronary artery disease, Ann. Intern. Med., 136(1), 54-71, 2002.
25. Edelman, E. R., Nugent, M. A., and Karnovsky, M. J., Perivascular and intravenous administration of basic fibroblast growth factor: vascular and solid organ deposition, Proc. Natl Acad. Sci. USA, 90(4), 1513-1517, 1993.
26. Lazarous, D. F., Shou, M., Scheinowitz, M., Hodge, E., Thirumurti, V., Kitsiou, A. N., Stiber, J. A., Lobo, A. D., Hunsberger, S., Guetta, E., Epstein, S. E., and Unger, E. F., Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury, Circulation, 94(5), 1074-1082, 1996.
27. Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., and Holash, J., Vascular-specific growth factors and blood vessel formation, Nature, 407(6801), 242-248, 2000.
28. Bowen-Pope, D. F., Malpass, T. W., Foster, D. M., and Ross, R., Platelet-derived growth factor in vivo: levels, activity, and rate of clearance, Blood, 64(2), 458-469, 1984.
29. Peters, M. C., Polverini, P. J., and Mooney, D. J., Engineering vascular networks in porous polymer matrices, J. Biomed. Mater. Res., 60(4), 668-678, 2002.
30. Colton, C. K., Implantable biohybrid artificial organs, Cell Transplant., 4(4), 415-436, 1995.
31. Hirschi, K. K., Skalak, T. C., Peirce, S. M., and Little, C. D., Vascular assembly in natural and engineered tissues, Ann. N. Y. Acad. Sci., 961, 223-242, 2002.
32. Conway, E. M., Collen, D., and Carmeliet, P., Molecular mechanisms of blood vessel growth, Cardiovasc. Res., 49(3), 507-521, 2001.
33. Polverini, P. J., The pathophysiology of angiogenesis, Crit. Rev. Oral. Biol. Med., 6(3), 230-247, 1995.
34. Nor, J. E., Christensen, J., Mooney, D. J., and Polverini, P. J., Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression, Am. J. Pathol., 154(2), 375-384, 1999.
35. Peters, M. C., Isenberg, B. C., Rowley, J. A., and Mooney, D. J., Release from alginate enhances the biological activity of vascular endothelial growth factor, J. Biomater. Sci.-Polym. Ed., 9(12), 1267-1278, 1998.
36. Benjamin, L. E., Hemo, I., and Keshet, E., A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125(9), 1591-1598, 1998.
37. Darland, D. C., and D’Amore, P. A., Blood vessel maturation: vascular development comes of age, J. Clin. Invest., 103(2), 157-158, 1999.
38. Cao, R., Brakenhielm, E., Li, X., Pietras, K., Widenfalk, J., Ostman, A., Eriksson, U., and Cao, Y., Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors, Faseb J, 16(12), 1575-1583, 2002.
39. Dunn, I. F., Heese, O., and Black, P. M., Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs, J. Neurooncol., 50(1-2), 121-137, 2000.
40. Thommen, R., Humar, R., Misevic, G., Pepper, M. S., Hahn, A. W., John, M., and Battegay, E. J., PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro, J. Cell. Biochem., 64(3), 403-413, 1997.
41. Richardson, T. P., Peters, M. C., Ennett, A. B., and Mooney, D. J., Polymeric system for dual growth factor delivery, Nat. Biotechnol., 19(11), 1029-1034, 2001.
42. Murphy, W. L., and Mooney, D. J., Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata, J. Am. Chem. Soc., 124(9), 1910-1917, 2002.
43. Murphy, W. L., Kohn, D. H., and Mooney, D. J., Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro, J. Biomed. Mater. Res., 50(1), 50-58, 2000.
44. Murphy, W. L., Simmons, C. A., Kaigler, D., and Mooney, D. J., Bone regeneration via a mineral substrate and induced angiogenesis, J. Dent. Res., 83(3), 204-210, 2004.
45. Street, J., Bao, M., deGuzman, L., Bunting, S., Peale, F. V., Jr., Ferrara, N., Steinmetz, H., Hoeffel, J., Cleland, J. L., Daugherty, A., van Bruggen, N., Redmond, H. P., Carano, R. A., and Filvaroff, E. H., Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover, Proc. Natl Acad. Sci. USA, 99(15), 9656-9661, 2002.
46. Murphy, W. L., Peters, M. C., Kohn, D. H., and Mooney, D. J., Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering, Biomaterials, 21(24), 2521-2527, 2000.
47. Shea, L. D., Wang, D., Franceschi, R. T., and Mooney, D. J., Engineered bone development from a pre-osteoblast cell line on three-dimensional scaffolds, Tissue Eng., 6(6), 605-617, 2000.
48. Cohen, H. et al., Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles, Gene Ther., 7(22), 1896-1905, 2000.
49. Hedley, M. L., Curley, J., and Urban, R., Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses, Nat. Med., 4(3), 365-368, 1998.
50. Bonadio, J., Smiley, E., Patil, P., and Goldstein, S., Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration, Nat. Med., 5(7), 753-759, 1999.
51. Fang, J. et al., Stimulation of new bone formation by direct transfer of osteogenic plasmid genes, Proc. Natl Acad. Sci. USA, 93(12), 5753-5758, 1996.
52. Yin, W., Smiley, E., Germiller, J., Mecham, R. P., Florer, J. B., Wenstrup, R. J., and Bonadio, J., Isolation of a novel latent transforming growth factor-beta binding protein gene (LTBP-3), J. Biol. Chem., 270(17), 10147-10160, 1995.
53. Romano, G., Pacilio, C., and Giordano, A., Gene transfer technology in therapy: current applications and future goals, Stem Cells, 17, 191-202, 1999.
54. Bonadio, J., Goldstein, S. A., and Levy, R. J., Gene therapy for tissue repair and regeneration, Adv. Drug Deliv. Rev., 33, 53-69, 1998.
55. Winn, S. R., Hu, Y., Sfeir, C., and Hollinger, J. O., Gene therapy approaches for modulating bone regeneration, Adv. Drug Deliv. Rev., 42(1-2), 121-138, 2000.
56. Mahato, R. I., Non-viral peptide-based approaches to gene delivery, J. Drug Target, 7(4), 249-268, 1999.
57. Li, S., and Huang, L., Nonviral gene therapy: promises and challenges, Gene Ther., 7, 31-34, 2000.
58. Adami, R. C., Collard, W. T., Gupta, S. A., Kwok, K. Y., Bonadio, J., and Rice, K. G., Stability of peptide-condensed plasmid DNA formulations, J. Pharm. Sci., 87(6), 678-683, 1998.
59. Huang, Y. C., Connell, M., Park, Y., Mooney, D. J., and Rice, K. G., Fabrication and in vitro testing of polymeric delivery system for condensed DNA, J. Biomed. Mater. Res. A, 67(4), 1384-1392, 2003.
60. Park, A., Wu, B., and Griffith, L. G., Integration of surface modification and 3D fabrication techniques to prepare patterned poly(L-lactide) substrates allowing regionally selective cell adhesion, J Biomater. Sci. Polym. Ed., 9(2), 89-110, 1998.
61. Eid, K. et al., Effect of RGD coating on osteocompatibility of PLGA-polymer disks in a rat tibial wound, J. Biomed. Mater. Res., 57(2), 224-231, 2001.
62. Riddle, K. and Mooney, D. J., Role of PLG Particle Size on Gas Foamed Scaffolds. Unpublished Results.